| Literature DB >> 28264654 |
Meenu Katoch1, Shipra Phull2, Shagun Vaid3, Shashank Singh3.
Abstract
BACKGROUND: Present study focuses on diversity and distribution analysis of endophytic fungi associated with different tissues of the Monarda citriodora Cerv. ex Lag. (Lamiaceae/Labiatae). Anticancer and antimicrobial potential of isolated endophytes have also been investigated.Entities:
Keywords: Antimicrobial activity; Cytotoxicity; Endophytic fungi; MTT assay; Monarda citriodora; Tube dilution method
Mesh:
Substances:
Year: 2017 PMID: 28264654 PMCID: PMC5339955 DOI: 10.1186/s12866-017-0961-2
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Summary of the fungal endophytes isolated from various tissues of M. citriodora
| S No. | Endophyte* | EMBL-Bank accession number | Most closely related strain (accession number) | Maximum Identity (%) |
|---|---|---|---|---|
| 1 | MC-1 L | KU527781 |
| 100 |
| 2 | MC-2 L | KU527782 |
| 99 |
| 3 | MC-3 L | KU527783 |
| 99 |
| 4 | MC-4 L | KU527784 |
| 100 |
| 5 | MC-5 L | KU527785 |
| 99 |
| 6 | MC-6 L | KU527786 |
| 98 |
| 7 | MC-8 L | KU680345 |
| 93 |
| 8 | MC-9 L | KU527787 |
| 99 |
| 9 | MC-10 L | KU527788 |
| 99 |
| 10 | MC-12 L | KU527789 |
| 99 |
| 11 | MC-14 L | KU527790 | Fusarium oxysporum_JX406507 | 99 |
| 12 | MC-15 L | KU527791 |
| 99 |
| 13 | MC-16 L | KU527792 |
| 99 |
| 14 | MC-17 L | KU527793 |
| 99 |
| 15 | MC-18 L | KU527794 |
| 99 |
| 16 | MC-20 L | KU680346 |
| 89 |
| 17 | MC-24 L | KU527795 |
| 100 |
| 18 | MC-25 L | KU527796 |
| 100 |
| 19 | MC-13R | KU527797 |
| 99 |
| 20 | MC-20R | KU527798 |
| 99 |
| 21 | MC-7 F | KU527799 |
| 99 |
| 22 | MC-14 F | KU527800 |
| 99 |
| 23 | MC-17 F | KU527801 |
| 99 |
| 24 | MC-21 F | KU527802 |
| 99 |
| 25 | MC-22 F | KU527803 |
| 100 |
| 26 | MC-23 F | KU527804 |
| 99 |
| 27 | MC-25 F | KU527805 |
| 99 |
| 28 | MC-26 F | KU527806 |
| 99 |
*last alphabet in the endophyte code represents the plant part to which endophyte was isolated i.e. L- leaf, R- Root and F- Flower etc
Fig. 1Phylogenetic position of the endophytic fungal isolates obtained from different tissues of the M. citriodora. The evolutionary history was inferred using neighbor-joining method [30]. The percentage of replicate trees in which the associated taxa clustered together in the bootstrap test (1000 replicates) is shown next to branches [32]. The evolutionary distances were computed using the maximum composite likelihood method [31]. Phylogenetic analyses were conducted in MEGA4 [28]
Tissue specific diversity indices of endophytic fungi isolated from Monarda citriodora
| Indices | Leaves | Roots | Flowers |
|---|---|---|---|
| Taxa_S | 18 | 2 | 6 |
| Individuals | 18 | 2 | 8 |
| Simpson’s Dominance_D | 0.055 | 0.5 | 0.218 |
| Simpson_1-D | 0.944 | 0.5 | 0.781 |
| Shannon_H | 2.890 | 0.693 | 1.667 |
| Evenness_e^H/S | 1 | 1 | 0.883 |
| Brillouin | 2.022 | 0.346 | 1.102 |
| Menhinick richness index | 4.243 | 1.414 | 2.121 |
| Margalef richness index | 5.882 | 1.443 | 2.404 |
| Equitability_J | 1 | 1 | 0.930 |
| Fisher_alpha diversity index | 0 | 0 | 10.91 |
| Berger-Parker dominance | 0.055 | 0.5 | 0.375 |
| Chao-1 | 171 | 3 | 16 |
Jaccard’s (Jc) and Sorenson’s similarity indices for endophytic fungi of Monarda citriodora
| Jaccard’s index/ Sorenson’s index | Leaf | root | Flower |
|---|---|---|---|
| Leaf | 1.0 | 0.1 | 0.16 |
| Root | 0.05 | 1.0 | 0.0 |
| Flower | 0.09 | 0.0 | 1.0 |
Anticancer activity of the extracts (100 μg mL−1) prepared from endophytic fungi isolated from M. citriodora
| Tissue | Lung | Colon | Breast | Prostate | ||
|---|---|---|---|---|---|---|
| S.No. | Cell line type | A549 | HCT116 | MCF7 | PC-3 | |
| Code | Conc (μg mL−1) | Percent Growth inhibition | ||||
| 1 | MC-1 L | 100 | 13 ± 0.8 | 0 ± 0 | 13 ± 0.3 | 16 ± 0.5 |
| 2 | MC-2 L | 100 | 35 ± 1 | 22 ± 0.3 | 52 ± 0 | 10 ± 0 |
| 3 | MC-3 L | 100 | 33 ± 0.5 | 12 ± 0.4 | 20 ± 0.4 | 41 ± 0.4 |
| 4 | MC-4 L*** | 100 | 67 ± 1 | 65 ± 0.2 | 91 ± 0.2 | 79 ± 0.3 |
| 5 | MC-5 L | 100 | 0 ± 0 | 47 ± 0 | 76 ± 0 | 51 ± 0.4 |
| 6 | MC-6 L | 100 | 27 ± 0.5 | 35 ± 0.5 | 54 ± 0.5 | 56 ± 0.4 |
| 7 | MC-8 L*** | 100 | 98 ± 1 | 99 ± 0.4 | 94 ± 0.4 | 95 ± 0.4 |
| 8 | MC-9 L | 100 | 22 ± 0.8 | 10 ± 0.2 | 14 ± 0.3 | 48 ± 0.2 |
| 9 | MC-10 L | 100 | 47 ± 0 | 18 ± 0.4 | 45 ± 0.4 | 49 ± 0 |
| 10 | MC-12 L | 100 | 34 ± 1 | 29 ± 0.6 | 37 ± 0.2 | 58 ± 0 |
| 11 | MC-14 L*** | 100 | 96 ± 1 | 100 ± 0.2 | 94 ± 0.3 | 100 ± 0.2 |
| 12 | MC-15 L | 100 | 24 ± 0.8 | 51 ± 0.8 | 86 ± 0 | 59 ± 0.5 |
| 13 | MC-16 L*** | 100 | 59 ± 0 | 47 ± 0.2 | 88 ± 0.2 | 61 ± 0.2 |
| 14 | MC-17 L | 100 | 48 ± 1 | 23 ± 0 | 23 ± 0.5 | 25 ± 0 |
| 15 | MC-18 L*** | 100 | 100 ± 0 | 93 ± 0.5 | 100 ± 0.2 | 90 ± 0.2 |
| 16 | MC-20 L*** | 100 | 77 ± 1 | 82 ± 0.5 | 77 ± 0.2 | 63 ± 0.5 |
| 17 | MC-24 L*** | 100 | 77 ± 1 | 99 ± 0.4 | 88 ± 0.4 | 96 ± 0 |
| 18 | MC-25 L*** | 100 | 88 ± 1 | 100 ± 0.2 | 94 ± 0.3 | 99 ± 0.4 |
| 19 | MC-13R | 100 | 40 ± 1 | 20 ± 0.6 | 35 ± 0.2 | 50 ± 0.5 |
| 20 | MC-20R | 100 | 10 ± 1 | 1 ± 0.4 | 26 ± 0.2 | 5 ± 0 |
| 21 | MC-7 F*** | 100 | 83 ± 1 | 87 ± 0 | 92 ± 0.5 | 74 ± 0 |
| 22 | MC-14 F*** | 100 | 99 ± 0 | 100 ± 0.4 | 91 ± 0.5 | 100 ± 0 |
| 23 | MC-17 F | 100 | 53 ± 1 | 28 ± 0 | 0 ± 0 | 7 ± 0 |
| 24 | MC-21 F | 100 | 0 ± 0 | 8 ± 0.3 | 11 ± 0.3 | 17 ± 0 |
| 25 | MC-22 F*** | 100 | 84 ± 1 | 75 ± 0.3 | 88 ± 0.4 | 80 ± 0.2 |
| 26 | MC-23 F | 100 | 0 ± 0 | 9 ± 0.2 | 0 ± 0 | 33 ± 0.4 |
| 27 | MC-25 F | 100 | 45 ± 1 | 90 ± 0.2 | 77 ± 0 | 81 ± 0.6 |
| 28 | MC-26 F | 100 | 94 ± 0 | 87 ± 0.5 | 97 ± 0.5 | 91 ± 0.2 |
| Paclitaxel | 1 μM | 79 ± 1 | ||||
| 5-Fluorouracil | 20 μM | 45 ± 0 | ||||
| Adriamycin | 1 μM | 46 ± 0.7 | ||||
| Mitomycin | 1 μM | 63 ± 0 | ||||
*** Highly Significant at P < 0.05
Anticancer activity (IC50 μg mL−1) of the extracts prepared from endophytic fungi isolated from M. citriodora against different human cancer cell lines
| Tissue | Colon | Lung | Prostate | Breast | |
|---|---|---|---|---|---|
| S.NO. | Cell line type | HCT-116 | A549 | PC-3 | T47D |
| Code | IC50 (μg mL−1) | ||||
| 1. | MC-8 L | 38.0 ± 0.08a | 24.3 ± 0.03 | 26.4 ± 0.06 | 19.7 ± 0.1a |
| 2. | MC-14 L | <10 ± 0.0 | <10 ± 0.0 | <10 ± 0.0 | <10 ± 0.0 |
| 3. | MC-18 L | 9.0 ± 0.02a | 4.8 ± 0.02b | 27.7 ± 0.06a,b | 19.6 ± 0.02 |
| 4. | MC-24 L | <10 ± 0.0 | <10 ± 0.0 | <10 ± 0.0 | <10 ± 0.0 |
| 5. | MC-25 L | <10 ± 0.0 | <10 ± 0.0 | 9.9 ± 0.02 | 12.7 ± 0.02 |
| 6. | MC-7 F | 32.2 ± 0.2a | 23.6 ± 0.02a,b | 32.3 ± 0.04b | 26 ± 0.04 |
| 7. | MC-14 F | 62.8 ± 0.5a,b | <10 ± 0.0a,c | 23.3 ± 0.02b | 42.7 ± 0.3c |
| 8. | MC-26 F | 11.1 ± 0.01 | <10 ± 0.0 | 11.7 ± 0.01 | 8.0 ± 0.02 |
| Paclitaxel in nM | 120 ± 0.2 | <10 ± 0.0 | 65 ± 0.3 | 777 ± 0.1 | |
same letters as superscript depicts significant difference at P < 0.05 between IC50 values of two cell lines (Additional file 1: Figure S2)
Zone of inhibition (mm) of the extracts prepared from endophytic fungi isolated from M. citriodora against different human pathogens
| Endophyte |
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
| MC-1 L | - | - | - | - | - | - | - |
| MC-2 L*** | 10 ± 0.2 | 21 ± 0.2 | 22 ± 0.3 | 21 ± 0 | 22 ± 0.2 | 23 ± 0.2 | - |
| MC-3 L | - | - | - | - | - | - | - |
| MC-4 L | - | 12 ± 0.6 | 14 ± 0.5 | 12 ± 0.2 | 15 ± 0 | 10 ± 0.2 | 6 ± 0.4 |
| MC-5 L | 10 ± 0.3 | - | - | - | - | - | - |
| MC-6 L | - | - | - | - | - | - | - |
| MC-8 L | - | 9 ± 0.5 | - | 10 ± 0.3 | - | - | - |
| MC-9 L | - | - | - | 25 ± 0.5 | - | - | - |
| MC-10 L | - | 15 ± 0.3 | - | - | 10 ± 0 | - | - |
| MC-12 L | 15 ± 0.3 | - | 14 ± 0.2 | 12 ± 0.3 | 16 ± 0.3 | - | 27.5 ± 0.2 |
| MC-14 L | 13 ± 0.5 | 12 ± 0.2 | 13 ± 0.6 | 12 ± 0 | 15 ± 0.3 | 11 ± 0.5 | 11 ± 0.2 |
| MC-15 L | - | 14 ± 0.5 | - | - | - | - | - |
| MC-16 L | - | 17 ± 0 | 30 | - | 12 ± 0.2 | 18 ± 0.5 | 10 ± 0 |
| MC-17 L | - | - | - | - | - | - | 10 ± 0 |
| MC-18 L*** | 35 ± 1 | 24 ± 0 | 35 ± 0.3 | 28 ± 0.5 | 32 ± 0.2 | 27 ± 0.3 | 9 ± 1 |
| MC-20 L | - | - | - | - | - | - | - |
| MC-24 L | 10 ± 0.2 | 22 ± 1 | 17 ± 0.2 | 26 ± 0.5 | 17 ± 0.4 | 15 ± 0.3 | - |
| MC-25 L | - | - | - | - | - | 10 ± 0.4 | - |
| MC-13R | - | 10 ± 0.2 | - | - | - | 10 ± 0.7 | - |
| MC-20R | - | 10 ± 0.3 | - | 10 ± 0.4 | - | - | - |
| MC-7 F | - | - | - | 12 ± 0.4 | - | - | - |
| MC-14 F | - | 12 ± 0.4 | - | 10 ± 0.3 | - | - | 9 ± 1 |
| MC-17 F | - | 15 ± 0.4 | - | - | - | - | - |
| MC-21 F | - | - | - | - | - | - | - |
| MC-22 F | - | - | - | - | 17 ± 0.4 | 13 ± 0.2 | - |
| MC-23 F | - | 16 ± 0 | 22 ± 0.3 | - | 12 ± 0.5 | - | - |
| MC-25 F | - | - | - | - | - | - | - |
| MC-26 F | - | - | - | - | - | - | - |
| Streptomycin | 22.5 ± 0.4 | 18 ± 0.5 | 18.7 ± 0 | 25 ± 0.2 | 20 ± 0.5 | 18 ± 0.7 | - |
| Amphotericin B | - | - | - | - | - | - | 24.6 ± 0.2 |
*** Highly Significant at P < 0.05
Antimicrobial activity (MIC/MBC values in μg mL−1) of the extracts prepared from endophytic fungi isolated from M. citriodora against different human pathogens
| Endophyte |
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
| MC-1 L | - | - | - | - | - | - | - |
| MC-2 L | >100 | 25 | 100 | 100 | 100 | >100 | - |
| MC-3 L | - | - | - | - | - | - | - |
| MC-4 L | - | >100 | >100 | >100 | >100 | >100 | - |
| MC-5 L | >100 | - | - | - | - | - | - |
| MC-6 L | - | - | - | - | - | - | - |
| MC-8 L | - | 100 | - | 100 | - | - | - |
| MC-9 L | - | - | - | >100 | - | - | - |
| MC-10 L | - | >100 | - | - | >100 | - | - |
| MC-12 L | >100 | - | >100 | >100 | >100 | - | - |
| MC-14 L | 12.5 | 12.5 (MBC) | 12.5 (MBC) | 25 (MBC) | 12.5 (MBC) | 12.5 | 25 |
| MC-15 L | - | >100 | - | - | - | - | - |
| MC-16 L | - | 100 | >100 | - | >100 | >100 | 100 |
| MC-17 L | - | - | - | - | - | - | - |
| MC-18 L | 50 | 25 | 25 | 25 | 12.5 | 12.5 | >100 |
| MC-20 L | - | - | - | - | - | - | - |
| MC-24 L | 12.5 | 12.5 | 12.5 | 12.5 | 12.5 (MBC) | 25 | - |
| MC-25 L | - | - | - | - | - | >100 | - |
| MC-13R | - | >100 | - | - | - | >100 | - |
| MC-20R | - | >100 | - | >100 | - | - | - |
| MC-7 F | - | - | - | >100 | - | - | - |
| MC-14 F | - | 12.5 (MBC) | - | 25 | - | - | 25 |
| MC-17 F | - | >100 | - | - | - | - | - |
| MC-21 F | - | - | - | - | - | - | - |
| MC-22 F | - | - | - | - | 100 | >100 | - |
| MC-23 F | - | >100 | >100 | - | >100 | - | - |
| MC-25 F | - | - | - | - | - | - | - |
| MC-26 F | - | - | -- | - | - | - | - |
| Streptomycin | 12.5 (MBC) | 12.5 (MBC) | 12.5 (MBC | 12.5 (MBC) | 12.5 | - | |
| Amphotericin | - | - | - | - | - |
| 6.25(MBC) |